A mathematical model for predicting the decline in estimated glomerular filtration rate at 12 months after parathyroidectomy in patients with primary hyperparathyroidism
https://doi.org/10.25881/18110193_2024_2_68
Abstract
Background. Primary hyperparathyroidism (PHPT) is an endocrine disease characterized by excessive production of parathyroid hormone (PTH) and elevated or high-normal blood calcium levels caused by primary pathology of the parathyroid glands. The "classic" complication of PHPT is a decrease in the kidneys filtration function. Parathyroidectomy (PTE) reduces the risks of further deterioration in filtration function; however, in some cases, this is not achieved.
Aim. To develop a mathematical model to predict the decline in estimated glomerular filtration rate (eGFR) 12 months after PTE in patients with PHPT, and implement it as a software.
Methods. Retrospective study included 140 patients with PHPT who underwent PTE in 1993–2010 and 2018–2020 at the National Medical Research Center of Endocrinology. Analyzed variables included sex, age, indicators of calciumphosphorus, purine, lipid, and carbohydrate metabolism, presence of PHPT complications, treatment for PHPT, histological examination of removed parathyroid tissue, development of postoperative hypocalcemia and transient hypoparathyroidism, therapy for postoperative hypocalcemia. The random forest method was used to build the mathematical model.
Results. To predict the decline in eGFR, a model using 24 predictors was built: sex, age, body mass index, PTH, ionized calcium, alkaline phosphatase, phosphorus, urea, eGFR, total cholesterol, diastolic blood pressure, SD(T-score)<-2.5/ SD(Z-score)<-2.0, CKD, duration of nephrolithiasis, use of angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors, preoperative use of cholecalciferol and cinacalcet, parathyroid hyperplasia/adenoma, postoperative hypocalcemia, dose of alfacalcidol and calcium supplements, postoperative use of cholecalciferol. The resulting model (http://194.87.111.169/cfr) predicts a decline in eGFR in patients with PHPT after PTE with a probability of 56.8–86.3% and excludes – with a probability of 85.6–97.7%.
Conclusion. A mathematical model to predict the decline in eGFR 12 months after PTE in patients with PHPT was developed, with an overall accuracy of 88%, 95% CI (79%; 93%). The model was implemented as a calculator that can be used in routine clinical practice
About the Authors
A. R. ElfimovaRussian Federation
A. K. Eremkina
Russian Federation
PhD
O. Yu. Rebrova
Russian Federation
DSc
E. V. Kovaleva
Russian Federation
PhD
N. G. Mokrysheva
Russian Federation
DSc, professor, Corresponding Member of the RAS
References
1. Mokrysheva N.G. Okoloshchitovidnye zhelezy. Meditsinskoe informatsionnoe agentstvo, 2019 (In Russ.)
2. Rubrikator klinicheskih rekomendacij. Pervichnyj giperparatireoz. Available from: http://cr.rosminzdrav.ru/schema/88_4. (In Russ.)
3. Mokrysheva NG, Rozhinskaia LI, Peretokina EV, et al. The results of analysis of the major epidemiological characteristics of primary hyperparathyroidism in Russia based on the registry data. Problems of Endocrinology. 2012; 58(5): 16-20. (In Russ.) doi: 10.14341/probl201258516-20.
4. Walker MD, Nickolas T, Kepley A, et al. Predictors of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab. 2014; 99(5): 1885-92. doi: 10.1210/jc.2013-4192.
5. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney int. 2020; 98(4S): S1-115. doi: 10.1016/j.kint.2020.06.019.
6. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney int. 2011; 80(1): 17-28. doi: 10.1038/ki.2010.483.
7. GBD CKD. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395(10225): 709-733. doi: 10.1016/S0140-6736(20)30045-3.
8. Rubrikator klinicheskih rekomendacij. Osteoporoz. Available from: https://cr.minzdrav.gov.ru/schema/87_4. (In Russ.)
9. Nelson HD, Haney EM, Chou R, et al. Screening for Osteoporosis: Systematic Review to Update the 2002 US Preventive Services Task Force Recommendation. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Jul. Report No.: 10-05145-EF-1.
10. Bonnick S. Bone Densitometry in Clinical Practice. Humana Press; 2004.
11. WHO Scientific Group Technical Report. Assessment of osteoporosis at the primary health-care level. Technical Report. 2007. Available from: https://frax.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf.
12. Rubrikator klinicheskih rekomendacij. Hronicheskaya bolezn' pochek (HBP). Available from: https://cr.minzdrav.gov.ru/recomend/469_2. (In Russ.)
13. Molnar C. Interpretable Machine Learning. A Guide for Making Black Box Models Explainable. 2023.
14. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005; 26(4): 97-122.
15. Walker MD, Dempster DW, McMahon DJ, et al. Effect of renal function on skeletal health in primary hyperparathyroidism. J Clin Endocrinol Metab. 2012; 97(5): 1501-7. doi: 10.1210/jc.2011-3072.
16. Tassone F, Guarnieri A, Castellano E, et al. Parathyroidectomy Halts the Deterioration of Renal Function in Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2015; 100(8): 3069-73. doi: 10.1210/jc.2015-2132.
17. Nair CG, Babu M, Jacob P, et al. Renal dysfunction in primary hyperparathyroidism; effect of Parathyroidectomy: A retrospective Cohort Study. Int J Surg. 2016; 36(Pt A): 383-7. doi: 10.1016/j.ijsu.2016.11.009.
18. Daumé H. A Course in Machine Learning. Self-published; 2015.
19. Fallah F. Hierarchical Quadratic Random Forest Classifier. 2023. arXiv:2306.01893.
20. Marco TR, Sameer S, Carlos G. Why Should I Trust You? Explaining the Predictions of Any Classifier. 2016. arXiv:1602.04938.
Review
For citations:
Elfimova A.R., Eremkina A.K., Rebrova O.Yu., Kovaleva E.V., Mokrysheva N.G. A mathematical model for predicting the decline in estimated glomerular filtration rate at 12 months after parathyroidectomy in patients with primary hyperparathyroidism. Medical Doctor and Information Technologies. 2024;(2):68-81. (In Russ.) https://doi.org/10.25881/18110193_2024_2_68